Follow this preprint

Respiratory syncytial virus (RSV) vaccine effectiveness and antibody correlates of protection among older adults in the Community Vaccine Effectiveness (CoVE) observational study

Elie-Tino Godonou, Amy P. Callear, Casey L. Juntila-Raymond, Dolapo Raji, Matthew Smith, Kalee E. Rumfelt, Claire M. Midgley, Leora R. Feldstein, Jefferson M. Jones, Melissa Briggs Hagen, Marisa C. Eisenberg, Adam S. Lauring, Arnold S. Monto, Abram L. Wagner, Emily T. Martin
doi: https://doi.org/10.1101/2025.03.14.25323981
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2025.03.14.25323981
History 
  • March 15, 2025.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Elie-Tino Godonou1,5 (elietino{at}umich.edu),
  2. Amy P. Callear1,
  3. Casey L. Juntila-Raymond1,
  4. Dolapo Raji1,
  5. Matthew Smith1,
  6. Kalee E. Rumfelt1,
  7. Claire M. Midgley2,
  8. Leora R Feldstein3,
  9. Jefferson M Jones3,
  10. Melissa Briggs Hagen2,
  11. Marisa C Eisenberg1,
  12. Adam S. Lauring4,
  13. Arnold S. Monto1,
  14. Abram L. Wagner1 and
  15. Emily Toth Martin1
  1. 1 University of Michigan School of Public Health;
  2. 2 National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention;
  3. 3 Centers for Disease Control and Prevention;
  4. 4 University of Michigan Medical School
  1. ↵* Corresponding author; email: elietino{at}umich.edu
Back to top
Posted March 15, 2025.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Respiratory syncytial virus (RSV) vaccine effectiveness and antibody correlates of protection among older adults in the Community Vaccine Effectiveness (CoVE) observational study
Elie-Tino Godonou, Amy P. Callear, Casey L. Juntila-Raymond, Dolapo Raji, Matthew Smith, Kalee E. Rumfelt, Claire M. Midgley, Leora R. Feldstein, Jefferson M. Jones, Melissa Briggs Hagen, Marisa C. Eisenberg, Adam S. Lauring, Arnold S. Monto, Abram L. Wagner, Emily T. Martin
medRxiv 2025.03.14.25323981; doi: https://doi.org/10.1101/2025.03.14.25323981
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.